{ "entity_id": "O-000876", "folder": "National-Health-and-Medical-Research-Council", "name": "National Health and Medical Research Council", "type": "Non-corporate Commonwealth Entity", "jurisdiction": "Commonwealth", "portfolio": "Health, Disability and Ageing", "website": "http://www.nhmrc.gov.au", "data_status": "rich", "completeness": { "has_strategy_brief": true, "has_strategy_structured": true, "has_vision": true, "has_kpi_targets": true, "has_kpi_results": true, "has_strategy_overview": true, "has_legislation_text": true, "has_legislation_structured": false, "has_global_initiatives_text": true, "has_ideas": true, "has_artifacts": true, "n_ideas": 12, "n_legislation": 0, "n_artifacts": 10, "n_kpi_targets": 1, "n_kpi_results": 1, "n_outcomes": 1, "verified_own_data": true }, "strategy_profile": { "status": "published", "confidence": "high", "summary": "Mission: To foster Australian participation in international networks and collaborative health and medical research.", "official_site_url": "http://www.nhmrc.gov.au", "source_documents": [ { "type": "strategie", "title": "International Engagement Strategy 2023–2026", "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf", "period": "2023", "confidence": "medium" }, { "type": "strategie", "title": "NHMRC Gender Equity Strategy", "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC_Gender_Equity_Strategy_FA.pdf", "period": null, "confidence": "medium" }, { "type": "annual_report", "title": "Annual Report", "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "period": "2018", "confidence": "high" }, { "type": "corporate_plan", "title": "Corporate Plan", "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "period": "2018", "confidence": "high" } ], "purpose": { "text": "Mission: To foster Australian participation in international networks and collaborative health and medical research.", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": 1, "source_deep_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1" }, "vision": { "text": "Vision: Australian health and medical researchers collaborate internationally to improve the health of the Australian community, our region and the world.", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": 1, "source_deep_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1" }, "strategic_priorities": [ { "title": "Priority 1: Collaboration in the Indo-Pacific region priorities and research impact", "description": "Priority 1: Collaboration in the Indo-Pacific region priorities and research impact", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": 1, "source_deep_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1" }, { "title": "Priority 2: Shared global health research priorities", "description": "Priority 2: Shared global health research priorities", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": 1, "source_deep_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1" }, { "title": "Priority 3: Researcher capability", "description": "Priority 3: Researcher capability", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": 1, "source_deep_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1" }, { "title": "Priority 4: International networks", "description": "Priority 4: International networks", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": 1, "source_deep_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1" } ], "values": [ { "name": "Transnational leadership and cooperation", "description": "", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": null }, { "name": "Information sharing", "description": "", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": null }, { "name": "Collaboration", "description": "", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": null }, { "name": "Sustainability", "description": "", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": null }, { "name": "Data sharing", "description": "", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": null }, { "name": "Open science", "description": "", "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": null } ], "outcomes": [ { "name": "Outcome 1: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research", "description": "NHMRC grants support Australian researchers to collaborate internationally to enhance their expertise, capabilities and networks.", "activities": [ "Engage in targeted funding opportunities to support regional capacity building", "Participate in global organisations and multilateral alliances that foster collaboration on global health issues" ], "source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "source_page": 1, "source_deep_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1" } ], "performance_measures": [ { "code": "CCE01", "measure": "The proportion of NHMRC grants with international collaborators", "target": "Increased", "latest_result": "Case studies used to demonstrate and promote the value of international collaboration", "status": "Achieved", "target_source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "target_source_page": 1, "result_source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "result_source_page": 1 } ], "document_alignment_terms": { "must_support": [ "Mission: To foster Australian participation in international networks and collaborative health and medical research.", "Vision: Australian health and medical researchers collaborate internationally to improve the health of the Australian community, our region and the world.", "Priority 1: Collaboration in the Indo-Pacific region priorities and research impact", "Priority 2: Shared global health research priorities", "Priority 3: Researcher capability", "Priority 4: International networks" ], "watch_terms": [ "The proportion of NHMRC grants with international collaborators" ], "avoid_claiming_without_evidence": [] }, "review_note": "" }, "strategy_brief_md": "# National Health and Medical Research Council — Strategy Brief\n\n**Reporting period**: 2024-25\n**Corporate plan in force**: 2025-26\n**Corporate Plan**: [2025-26](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf)\n\n## Vision\n\n> Vision: Australian health and medical researchers collaborate internationally to improve the health of the Australian community, our region and the world. [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n\n## Our purpose / purposes\n\n> Mission: To foster Australian participation in international networks and collaborative health and medical research. [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n\n## How we deliver\n\n> How we deliver: Collaborate with international funding partners on opportunities to address shared health priorities and build regional capacity. [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n\n## Government priorities for this department\n\n- Priority 1: Collaboration in the Indo-Pacific region priorities and research impact [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n- Priority 2: Shared global health research priorities [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n- Priority 3: Researcher capability [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n- Priority 4: International networks [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n\n## Outcomes\n\n### Outcome 1: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nNHMRC grants support Australian researchers to collaborate internationally to enhance their expertise, capabilities and networks. [[CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1)]\n\n**Key activities:**\n- Engage in targeted funding opportunities to support regional capacity building\n- Participate in global organisations and multilateral alliances that foster collaboration on global health issues\n\n## Values and principles\n\n_International Engagement Strategy_\n\n- Transnational leadership and cooperation\n- Information sharing\n- Collaboration\n- Sustainability\n- Data sharing\n- Open science\n\n## What they will measure themselves on this year (targets from 2025-26 corporate plan)\n\n| Code | Measure | Target | Source |\n|---|---|---|---|\n| CCE01 | The proportion of NHMRC grants with international collaborators | Increased | [CP p.1](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22#page=1)(https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf#page=1) |\n\n## How they performed last year (results from 2024-25 annual report)\n\n| Code | Measure | Result | Status | Source |\n|---|---|---|---|---|\n| CCE01 | The proportion of NHMRC grants with international collaborators | Case studies used to demonstrate and promote the value of international collaboration | Achieved | AR p.1 |", "strategy_overview_evidence_md": null, "internal_strategy_evidence_md": "# National Health and Medical Research Council - Strategy, Performance, and Operating Profile\n\n**Generated at**: 2026-05-09T21:56:42.905625+00:00\n**Entity ID**: O-000876\n**Entity type**: Non-corporate Commonwealth Entity\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n**Website**: http://www.nhmrc.gov.au\n\n> Draft generated from scraped source material. Treat this as an evidence pack for editorial review, not a final judgement.\n\n## Source Coverage\n\n| Source type | Count |\n|---|---:|\n| global-intelligence | 3 |\n| other-pdfs | 5 |\n| pages | 35 |\n| reviews | 1 |\n| strategies | 2 |\n\n## Executive Readout\n\n### Purpose\n\n- [Page 10]\nlayouts and all other rights resulting from intellectual activity in the industrial, scientific,\nliterary or artistic fields but excludes Moral Rights and rights in relation to Confidential\nInformation;\n\"Interest\" (in clauses 8.11, 15.2 and 16.6) means interest calculated at an interest\nrate equal to the 90 day bank-accepted bill rate (available from the Reserve Bank of\nAustralia) less 10 basis points, on a daily compounding basis;\n\"Material\" means anything in relation to which Intellectual Property rights arise;\n“Misconduct” includes Research Misconduct and fraudulent conduct.\n\"Misleading Information\" includes, but is not limited to, information that:\na. is false, including making a false claim in relation to a publication record\n(e.g. describing a paper as being ‘in press’ or ‘accepted’ if it has only been\nsubmitted);\nb.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- Have a minimum of 2 years proven track record of:\na. operating under the legal name that is registered with the ABN – in some\ncircumstances the track record under a prior legal name or ABN may be\nconsidered.\nb. having the objective to improve health and medical outcomes for Australia by\nconducting ethical and responsible health and medical research at locations in\nAustralia.\nc. operating as one of the legal entity types listed in Question 8 of this form.\nd. operating a publicly searchable website under the applicant’s name.\ne. having an independent governing board or council with scientific and\nadministrative experience, skills and qualifications.\nf. successfully applying for and administering research grants from any\ngovernment or non-government entity, for example by operating as a\nParticipating Institution under the leadership of an NHMRC Administering\nInstitution.\ng.\n Source: `other-pdfs/NHMRC-Administering--20Institution-Status-Application-Form-2.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Research%20Administration/NHMRC-Administering-%20Institution-Status-Application-Form-2.pdf)`\n- For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- Health may, upon written notice to the Eligible Organisation, immediately take any of the\nactions specified in clause 16.2 if:\na. it reasonably considers that the Eligible Organisation or a Participating Institution\nhas failed to comply with a term or condition of this Agreement, the requirements\nof being an Eligible Organisation, the NHMRC Approved Standards and\nGuidelines or a Funding Policy;\nb. within the last 3 years a Specified Person or any other personnel working on a\nResearch Activity has been found to have engaged in proven Misconduct related\nto funding provided by Health or NHMRC;\nc. it reasonably considers that the Eligible Organisation or Specified Personnel have\nprovided Misleading Information, including in an Application or a Report;\nd. it reasonably considers that the purposes and activities of the Eligible\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n\n### Role and Functions\n\n- By 1990, it was estimated that there were over 100 IECs throughout Australia and in 2005, there are more than 220. (IECs are now known as Human Research Ethics Committees.)\nThe\nNational Health and Medical Research Council Act 1992\nestablishes the Role of the CEO whose functions include the issue of \"guidelines for the conduct of medical research involving humans\".\n Source: `pages/announcements-index__22.html (http://www.nhmrc.gov.au/research-policy/ethics/national-statement-ethical-conduct-human-research)`\n- For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 12,13,14]\nion to be accountable for the administration of the Funds, the\nconduct of a Research Activity or other matter;\n\"Salary Support Package\" means, in respect of a Research Activity, the Funds for\nthe salaries or Stipends and related costs of the Research Activity's Personnel\nidentified in the Approved Budget for the Research Activity;\n\"Schedule\" means a document signed by the Parties (including in accordance with\nclauses 2.3 and 4), which is substantially in the form of, and contains the information\nrequired by, the template provided by Health and includes any attachment to the\nSchedule;\n\"Scheme\" means a funding scheme or grant opportunity administered by NHMRC\nand funded by the MRFF, including:\na. a Research Support Scheme;\nb. a People Support Scheme; and\nc. any Other Scheme;\nPage 11 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- Without limiting the breadth of this\nclause 6.5, each Formal Agreement must:\na. specify the Funding to be provided by the Eligible Organisation to the Participating\nInstitution for the Research Activity as well as the role of, and any financial or in-\nkind contribution to be provided by, the Participating Institution for the Research\nActivity;\nb. outline the part of the Research Activity to be undertaken by the Participating\nInstitution;\nc. outline each of the Eligible Organisation's and Participating Institution's\nresponsibilities for the payment of salaries and any Stipends for the Specified\nPersonnel for that Research Activity;\nd. outline the respective roles and responsibilities of Personnel from the Eligible\nOrganisation and the Participating Institution to ensure sound research\ngovernance, including notification of Misconduct and notification and management\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- Responsible Officer (RO) contact details:\nPrimary RO Additional RO\nTitle\nFirst name\nLast name\nPosition\nPhone\nMobile\nEmail\nThe Chief Financial Officer (CFO), as defined in the NHMRC Funding Agreement, must be:\n• the person with principal responsibility for accounting and financial management within\nthe Administering Institution\nPage 15 of 17\nLast updated 5 November 2025\n Source: `other-pdfs/NHMRC-Administering--20Institution-Status-Application-Form-2.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Research%20Administration/NHMRC-Administering-%20Institution-Status-Application-Form-2.pdf)`\n- Have a minimum of 2 years proven track record of:\na. operating under the legal name that is registered with the ABN – in some\ncircumstances the track record under a prior legal name or ABN may be\nconsidered.\nb. having the objective to improve health and medical outcomes for Australia by\nconducting ethical and responsible health and medical research at locations in\nAustralia.\nc. operating as one of the legal entity types listed in Question 8 of this form.\nd. operating a publicly searchable website under the applicant’s name.\ne. having an independent governing board or council with scientific and\nadministrative experience, skills and qualifications.\nf. successfully applying for and administering research grants from any\ngovernment or non-government entity, for example by operating as a\nParticipating Institution under the leadership of an NHMRC Administering\nInstitution.\ng.\n Source: `other-pdfs/NHMRC-Administering--20Institution-Status-Application-Form-2.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Research%20Administration/NHMRC-Administering-%20Institution-Status-Application-Form-2.pdf)`\n\n### Strategic Priorities\n\n- State of the Region 2019: Health Security in the Indo-Pacific.\nhttps://indopacifichealthsecurity.dfat.gov.au/sites/default/files/2022-07/Indo-Pacific%20Health%20Security%20-%20State%20of%20the%20Region%202019.pdf\n4\nGlobal Research on Antimicrobial Resistance, 'Global burden of bacterial AMR'\nhttps://www.tropicalmedicine.ox.ac.uk/gram/research/global-burden-of-bacterial-antimicrobial-resistance\n5\nWorld Health Organization, 'WHO Strategic Priorities on Antimicrobial Resistance'\n6\nLow et al (2015) Non-communicable diseases in the Asia-Pacific region: Prevalence, risk factors and community-based prevention.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- NHMRC expenditure by Former National Health Priority Areas 2016 to 2025\nFormer National Health Priority Areas\n2016\n$ million\n2017\n$ million\n2018\n$ million\n2019\n$ million\n2020\n$ million\n2021\n$ million\n2022\n$ million\n2023\n$ million\n2024\n$ million\n2025\n$ million\nArthritis and Osteoporosis\n19.3\n18.9\n17.5\n18.3\n16.1\n14.8\n16\n16.9\n17.8\n20.0\nAsthma\n15.3\n13.3\n15.7\n13.8\n13.3\n14.1\n12.5\n11.8\n9.2\n8.3\nCancer\n170.6\n175.8\n178.9\n181.6\n170.2\n153.7\n158.9\n165.6\n164.7\n186.0\nCardiovascular Disease\n114.9\n111.4\n105.3\n112.6\n107.6\n102.5\n97.5\n93.1\n88.8\n87.8\nDementia\n1\n45.6\n50.2\n60.9\n71.2\n64.1\n55.3\n51.5\n44.2\n38.8\n39.7\nDiabetes\n65.0\n57.7\n50.7\n46.5\n45.6\n42.6\n42.3\n41.4\n34.1\n30.0\nInjury\n45.8\n44.2\n49.9\n51.1\n49.8\n46.6\n49.8\n49.2\n48.8\n56.1\nMental Health\n2\n91.1\n93.4\n104.9\n110.2\n103.9\n102.3\n100.8\n105.5\n102.8\n119.1\nObesity\n28.1\n27.6\n23.0\n23.5\n24.3\n23.1\n20\n18.4\n16\n16.2\n1\n Source: `pages/strategies-index__04.html (http://www.nhmrc.gov.au/funding/outcomes-and-data-research/research-funding-statistics-and-data)`\n- 16\nClimate Change: an urgent health priority (April 2022)\nhttps://aahms.org/wp-content/uploads/2022/06/Health-impacts-of-climate-change.pdf\n17\nhttps://www.nhmrc.gov.au/about-us/news-centre/which-treatments-will-save-lives-icu\n18\nCSIRO Futures (2022) Strengthening Australia’s Pandemic Preparedness: Science and technology enabled solutions.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report\n Source: `pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)`\n- [pages 25,26,27,28,29,30]\nccess eProtocol\n(c) set a secure password for eProtocol (i.e. combination of upper\nand lower case letters, numbers and symbols) and change as\ninstructed\n(d) limit disclosure of the password to Bellberry staff\n(e) where operating systems and internet browsers automatically\ncreate a download of documents upon opening and save these to\nthe desktop or a download folder, ensure that automatically saved\ndocuments are securely deleted and the trash emptied at the close\nof each user session\n(f) sign out of eProtocol when a session has been finished\n(g) keep any relevant computer software, personal firewall and\nantivirus protection up to date\n(h) comply with any other IT security policy as determined by\nBellberry.\n Source: `reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)`\n- [Page 10]\nlayouts and all other rights resulting from intellectual activity in the industrial, scientific,\nliterary or artistic fields but excludes Moral Rights and rights in relation to Confidential\nInformation;\n\"Interest\" (in clauses 8.11, 15.2 and 16.6) means interest calculated at an interest\nrate equal to the 90 day bank-accepted bill rate (available from the Reserve Bank of\nAustralia) less 10 basis points, on a daily compounding basis;\n\"Material\" means anything in relation to which Intellectual Property rights arise;\n“Misconduct” includes Research Misconduct and fraudulent conduct.\n\"Misleading Information\" includes, but is not limited to, information that:\na. is false, including making a false claim in relation to a publication record\n(e.g. describing a paper as being ‘in press’ or ‘accepted’ if it has only been\nsubmitted);\nb.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 12,13,14]\nion to be accountable for the administration of the Funds, the\nconduct of a Research Activity or other matter;\n\"Salary Support Package\" means, in respect of a Research Activity, the Funds for\nthe salaries or Stipends and related costs of the Research Activity's Personnel\nidentified in the Approved Budget for the Research Activity;\n\"Schedule\" means a document signed by the Parties (including in accordance with\nclauses 2.3 and 4), which is substantially in the form of, and contains the information\nrequired by, the template provided by Health and includes any attachment to the\nSchedule;\n\"Scheme\" means a funding scheme or grant opportunity administered by NHMRC\nand funded by the MRFF, including:\na. a Research Support Scheme;\nb. a People Support Scheme; and\nc. any Other Scheme;\nPage 11 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 34]\ni. the Eligible Organisation or a Participating Institution becomes unable to pay all its\ndebts as and when they become due and payable;\nj. the Eligible Organisation or a Participating Institution has applied to come under,\nreceived a notice requiring it to show cause why it should not come under, or has\notherwise come under one of the forms of external administration referred to in\nChapter 5 of the Corporations Act 2001 (Cth) or equivalent provisions in\nlegislation of the States and Territories pertaining to incorporated associations or\nChapter 11 of the Corporations (Aboriginal and Torres Strait Islander) Act 2006\n(Cth) or an order has been made for the purpose of placing the Eligible\nOrganisation or a Participating Institution under external administration;\nk. the Eligible Organisation or a Participating Institution undergoes a Change of\nControl;\nl.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 46]\nf. it or a Participating Institution has applied to come under, received a notice\nrequiring it to show cause why it should not come under, or has otherwise come\nunder one of the forms of external administration referred to in Chapter 5 of the\nCorporations Act 2001 (Cth) or equivalent provisions in legislation of the States\nand Territories pertaining to incorporated associations or Chapter 11 of the\nCorporations (Aboriginal and Torres Strait Islander) Act 2006 (Cth) or an order\nhas been made for the purpose of placing the Eligible Organisation or\nParticipating Institution under external administration;\ng. it or a Participating Institution undergoes a Change of Control;\nh. it becomes aware of a Probity Event, or a Conflict of Interest;\ni. it becomes aware of any delay of six months or more that is likely to occur in\nrelation to the performance of a Research Activity;\nj.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n\n## KPIs, Targets, and Where They Are At\n\n- [pages 32,33,34]\nthe Eligible Organisation other than\nin accordance with this Agreement (or, where the Funds have been provided\nto a Participating Institution, by that Participating Institution other than in\naccordance with its Formal Agreement); and\nf. where part of the Agreement has been removed as a result of the reduction in the\nscope of the Agreement (the Removed Part), Health will be entitled to recover\nfrom the Eligible Organisation any part of the Funds provided for the Removed\nPart that:\ni. is not due and payable by the Eligible Organisation in accordance with this\nAgreement (and, where the Funds have been provided to a Participating\nInstitution, by that Participating Institution in accordance with its Formal\nAgreement) for the Removed Part by the earlier of the date the notice is\nPage 31 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- Health will not be liable to pay any amounts under this clause 15 that would, when\nadded to any payments already paid to the Eligible Organisation under this\nAgreement, together exceed the total Funding specified in this Agreement; and\ne. where the Agreement is terminated, Health will be entitled to recover from the\nEligible Organisation any part of the Funds that:\ni. is not due and payable by the Eligible Organisation in accordance with this\nAgreement (and, where the Funds have been provided to a Participating\nInstitution, by that Participating Institution in accordance with its Formal\nAgreement) by the earlier of the date that the notice is received or is\ndeemed by clause 31.3 to be received by the Eligible Organisation; or\nii. has, in Health's opinion, been spent by the Eligible Organisation other than\nin accordance with this Agreement (or, where the Funds have been provided\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 25,26,27,28,29,30]\nccess eProtocol\n(c) set a secure password for eProtocol (i.e. combination of upper\nand lower case letters, numbers and symbols) and change as\ninstructed\n(d) limit disclosure of the password to Bellberry staff\n(e) where operating systems and internet browsers automatically\ncreate a download of documents upon opening and save these to\nthe desktop or a download folder, ensure that automatically saved\ndocuments are securely deleted and the trash emptied at the close\nof each user session\n(f) sign out of eProtocol when a session has been finished\n(g) keep any relevant computer software, personal firewall and\nantivirus protection up to date\n(h) comply with any other IT security policy as determined by\nBellberry.\n Source: `reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)`\n- NHMRC expenditure by Former National Health Priority Areas 2016 to 2025\nFormer National Health Priority Areas\n2016\n$ million\n2017\n$ million\n2018\n$ million\n2019\n$ million\n2020\n$ million\n2021\n$ million\n2022\n$ million\n2023\n$ million\n2024\n$ million\n2025\n$ million\nArthritis and Osteoporosis\n19.3\n18.9\n17.5\n18.3\n16.1\n14.8\n16\n16.9\n17.8\n20.0\nAsthma\n15.3\n13.3\n15.7\n13.8\n13.3\n14.1\n12.5\n11.8\n9.2\n8.3\nCancer\n170.6\n175.8\n178.9\n181.6\n170.2\n153.7\n158.9\n165.6\n164.7\n186.0\nCardiovascular Disease\n114.9\n111.4\n105.3\n112.6\n107.6\n102.5\n97.5\n93.1\n88.8\n87.8\nDementia\n1\n45.6\n50.2\n60.9\n71.2\n64.1\n55.3\n51.5\n44.2\n38.8\n39.7\nDiabetes\n65.0\n57.7\n50.7\n46.5\n45.6\n42.6\n42.3\n41.4\n34.1\n30.0\nInjury\n45.8\n44.2\n49.9\n51.1\n49.8\n46.6\n49.8\n49.2\n48.8\n56.1\nMental Health\n2\n91.1\n93.4\n104.9\n110.2\n103.9\n102.3\n100.8\n105.5\n102.8\n119.1\nObesity\n28.1\n27.6\n23.0\n23.5\n24.3\n23.1\n20\n18.4\n16\n16.2\n1\n Source: `pages/strategies-index__04.html (http://www.nhmrc.gov.au/funding/outcomes-and-data-research/research-funding-statistics-and-data)`\n- 10\nThe COVID-19 pandemic has brought the risks associated with multimorbidity into the spotlight as many of those who have experienced severe illness and death as a result of COVID-19 have had one or more underlying chronic conditions.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- State of the Region 2019: Health Security in the Indo-Pacific.\nhttps://indopacifichealthsecurity.dfat.gov.au/sites/default/files/2022-07/Indo-Pacific%20Health%20Security%20-%20State%20of%20the%20Region%202019.pdf\n4\nGlobal Research on Antimicrobial Resistance, 'Global burden of bacterial AMR'\nhttps://www.tropicalmedicine.ox.ac.uk/gram/research/global-burden-of-bacterial-antimicrobial-resistance\n5\nWorld Health Organization, 'WHO Strategic Priorities on Antimicrobial Resistance'\n6\nLow et al (2015) Non-communicable diseases in the Asia-Pacific region: Prevalence, risk factors and community-based prevention.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- 16\nClimate Change: an urgent health priority (April 2022)\nhttps://aahms.org/wp-content/uploads/2022/06/Health-impacts-of-climate-change.pdf\n17\nhttps://www.nhmrc.gov.au/about-us/news-centre/which-treatments-will-save-lives-icu\n18\nCSIRO Futures (2022) Strengthening Australia’s Pandemic Preparedness: Science and technology enabled solutions.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 10]\nlayouts and all other rights resulting from intellectual activity in the industrial, scientific,\nliterary or artistic fields but excludes Moral Rights and rights in relation to Confidential\nInformation;\n\"Interest\" (in clauses 8.11, 15.2 and 16.6) means interest calculated at an interest\nrate equal to the 90 day bank-accepted bill rate (available from the Reserve Bank of\nAustralia) less 10 basis points, on a daily compounding basis;\n\"Material\" means anything in relation to which Intellectual Property rights arise;\n“Misconduct” includes Research Misconduct and fraudulent conduct.\n\"Misleading Information\" includes, but is not limited to, information that:\na. is false, including making a false claim in relation to a publication record\n(e.g. describing a paper as being ‘in press’ or ‘accepted’ if it has only been\nsubmitted);\nb.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 12,13,14]\nion to be accountable for the administration of the Funds, the\nconduct of a Research Activity or other matter;\n\"Salary Support Package\" means, in respect of a Research Activity, the Funds for\nthe salaries or Stipends and related costs of the Research Activity's Personnel\nidentified in the Approved Budget for the Research Activity;\n\"Schedule\" means a document signed by the Parties (including in accordance with\nclauses 2.3 and 4), which is substantially in the form of, and contains the information\nrequired by, the template provided by Health and includes any attachment to the\nSchedule;\n\"Scheme\" means a funding scheme or grant opportunity administered by NHMRC\nand funded by the MRFF, including:\na. a Research Support Scheme;\nb. a People Support Scheme; and\nc. any Other Scheme;\nPage 11 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 34]\ni. the Eligible Organisation or a Participating Institution becomes unable to pay all its\ndebts as and when they become due and payable;\nj. the Eligible Organisation or a Participating Institution has applied to come under,\nreceived a notice requiring it to show cause why it should not come under, or has\notherwise come under one of the forms of external administration referred to in\nChapter 5 of the Corporations Act 2001 (Cth) or equivalent provisions in\nlegislation of the States and Territories pertaining to incorporated associations or\nChapter 11 of the Corporations (Aboriginal and Torres Strait Islander) Act 2006\n(Cth) or an order has been made for the purpose of placing the Eligible\nOrganisation or a Participating Institution under external administration;\nk. the Eligible Organisation or a Participating Institution undergoes a Change of\nControl;\nl.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- The Eligible Organisation indemnifies (and agrees to keep indemnified) Health, Health's\nPersonnel, NHMRC and NHMRC’s Personnel (in this clause 19 referred to as ‘those\nindemnified’) from and against any:\na. cost or liability incurred by those indemnified;\nb. loss of or damage to property of those indemnified; or\nc. loss or expense incurred by those indemnified in dealing with any claim against\nthem, including legal costs and expenses on a solicitor/own client basis and the\ncost of time spent, resources used, or disbursements paid by those indemnified,\narising from:\nd. any act or omission by the Eligible Organisation, its Personnel or a subcontractor\n(including a Participating Institution) in connection with this Agreement, where\nthere was fault on the part of the person whose conduct gave rise to that cost,\nliability, loss, damage, or expense;\ne.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 46]\nf. it or a Participating Institution has applied to come under, received a notice\nrequiring it to show cause why it should not come under, or has otherwise come\nunder one of the forms of external administration referred to in Chapter 5 of the\nCorporations Act 2001 (Cth) or equivalent provisions in legislation of the States\nand Territories pertaining to incorporated associations or Chapter 11 of the\nCorporations (Aboriginal and Torres Strait Islander) Act 2006 (Cth) or an order\nhas been made for the purpose of placing the Eligible Organisation or\nParticipating Institution under external administration;\ng. it or a Participating Institution undergoes a Change of Control;\nh. it becomes aware of a Probity Event, or a Conflict of Interest;\ni. it becomes aware of any delay of six months or more that is likely to occur in\nrelation to the performance of a Research Activity;\nj.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report\n Source: `pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)`\n\n## Key Metrics\n\n| Values found | Evidence | Source |\n|---|---|---|\n| $10,000, $10,000, | Research Support Scheme or any Other Scheme – the budget contained in\nthe Application for that Research Activity to the extent that budget has been\napproved by Health;\n\"Asset\" means:\na. any item of property (including Equipment and animals) which has a GST-\nexclusive cost of more than $10,000; and\nb. any group or class of items of property (including Equipment and animals)\nthat as a group or class of items has a total GST-exclusive cost of more t | `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)` |\n| $5 million, 5 million | If Research Committee considers a potential TCR topic a high priority, it will recommend a budget allocation from the Medical Research Endowment Account (MREA) of up to $5 million for a period of up to 5 years. | `pages/strategies-index__12.html (http://www.nhmrc.gov.au/research-policy/research-priorities/framework-identifying-and-prioritising-targeted-calls-research)` |\n| $32.0 million, 32.0 million | To date, the 2026 NHMRC grant application round has resulted in the commitment of more than $32.0 million to fund 14 grants for health and medical research. | `pages/strategies-index__02.html (http://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds)` |\n| $75 million, 75 million | From 2019 onwards, since the introduction of the Clinical Trials and Cohort Studies Grant scheme, 28 clinical trials (with at least 1 international collaborator) have been funded through this scheme, with a total investment of $75 million. | `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)` |\n| $10 million, 10 million | The Eligible Organisation must, for so long as any obligations remain in connection with\nthis Agreement, effect and maintain the following insurances:\na. workers’ compensation insurance as required by law;\nb. a public liability insurance policy for an amount sufficient to cover all the\nobligations of the Eligible Organisation under this Agreement, including those\nwhich survive the expiration or termination of this Agreement; and\nc. insurance to c | `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)` |\n| $7, $8 | �P��T\u0006�.?K�R-�> Q�UR��\u0004���ɐ(� \u0001�����\u001a>���7�HRb� SX� X�Db��V%���X��\u000fjے:^'�!�O�RPG��\u000e\"���̸\\�����X�%{�r��\u000e����U�u�\u001dXy��Ҫ'�?�\u0015�S���\u0004�~O\u000f������\n��H�𤞌��'���1\u0017���\u0007\u0012\n�.4�x��+��\u0010�&�X\n�\u0002pf��\u0018�#l'QL�x]_�l��iQ�H\u0018�@b��q���\u0019'��\u0010d�\u0016PF\u0013N����b�O���h�(�\u000f3œ\u0015��Lv~�x\u0005=Mao8s�7\\|��\n�\"~�\u000e��7~�1��ni@\u0014�\u0005�\u0010�� ��wY\f���~���\u0012$7\u00156yI�U#+K��\u001d�?j8\n�WTﺪ�u\u0006��Uz�ۀ\n]A�\"�\u0011u`i�*S��6E1�?�\u0007�\u0016�1�L��'�=L1�b\n8\u000f���R��\u0019Q�&�\u0017���q�;�>\u0001�ìJ�\\N�{\u000bꏫQ\u0001`l6(\u001dų:�m�iH{�\u0015\u0003Q��(�\u0018�*�퀷�\u001f�\u0011�=��\u0010��q\fYf(��e� | `pages/announcements-index__18.html (https://www.nhmrc.gov.au/sites/default/files/images/NHMRC-ARC%20AI%20joint%20statement%20policy%20on%20use%20of%20generative%20AI%20in%20grant%20applications%20and%20assessment.pdf)` |\n| $3 | -���\u0002R��O�T\br�đI����y\b:G6��\u000fd;\u0012�.�f?ul\u001f���G�\u0019�Ö\u001d �*�.���1�X��7\u0002�8�����v����\u0004�Lv�İ����\u0016-\u0014�/�(\u001e.?Ƶ�r���\u0001�*\u0017SQ�����,�$lы/\n��n\u0013��\u0014zt�[f\u000b��?\u001b[�jD�R�х�Lz��\nB�K��\n�#HO$3G�7,x6���\\|�A@��Mx��n��E��[��v��������C���Jo�UI�>\bjM�Ő�\u0011&��\u001c��xϵ��~\u0003�\u0010��N���v��[\u0011�:��r�/*��eB��\\|\u000f�xl�v�Q0�Mo��xsO�VO�o\nV�����i���E�[��E\u0003\u0003e[\u0013�e�;χ���C�=�t���\u001cd�l;�hP�O���MRs��(�\u0007\u0010�C�\u0006שW���D�I\u0012(�u�hK��^PcM$��m�\u00102�ȝ>?��\u001fr��R�1\u0016�\u001a�p��&k����ۡ\u0005�j\u0013#�>bl���\u0006�\\9���@y��\u0019q���ז�?>�\f��xv��q�\"���~7�� | `pages/announcements-index__18.html (https://www.nhmrc.gov.au/sites/default/files/images/NHMRC-ARC%20AI%20joint%20statement%20policy%20on%20use%20of%20generative%20AI%20in%20grant%20applications%20and%20assessment.pdf)` |\n| $4 | M��RGvS�\n�;<:��\u0014�X�>��w2�I-\u001b`��H\u001cЊ\u0007����BĈ>b\u0007��ڟ��\u0006\u0013f��&��W��τ����G��2Ǥ�L�(\u0002�#���B�gx\\|\u001c�u�\u0007GJɘ�*��3;�\u0006��#��T\f�E���)d3\u000ew���\u0019��e���La{W��~�gu�B$Z�%��p�o�߮,mN�ٰcH���{���\u0018����hn����XO ���l��=\n�\u0001J��q\u0012ybV��\u0014�\u0004�ؠ�=�\n}ްD?�N<�8���#�o܌��zmO�^C��a)M?ɧ\u0015��xű\u0015m�PG�\u0006G[��嘭�)\u0007%S�n\u001c\\|�S��\u0003��T\"f��i��\nu�\u0014��'�S#1�B\u0001��n�Y�v\u0004\u001f���щ�\\c2��f��jV˂��{v��\n�Lp�#\u0007��.� hy\u000f�\u0012sN��y��\u0007�~�\\|�l4�\u000f;Ut�\u0019v��\u0005m��\u00171\u0016��Mx\u0010�x�g���/��V�\u0016�>�\u0015n�U���\u0010��\f�X�<�gh�MEW`dW�s6�0 ��\u001fJT\u0013\u0011\u0010{i}�X����\u0015sp$י� | `pages/reforms-index__15.html (http://www.nhmrc.gov.au/file/14281/download?token=yf_EGIEL)` |\n| $4 | �66X�r~ؐ��#�?N�rAeg=]��%�_��VH\\���?1�Ri�f��Mo)��tU�:�VG��:Ѣ�\n׫)x�\"�����n�����`\u0002��<�W�.겯=\\|��%Ē?\u0001\u0004�o(�\"\u0012/{�\\|0�<'��o��$4OO�>��<\u001a��<�\u001ca�nr\u0018>�ģ��'�����f��\u0001TSL�fV��h�G�OM1Q�Te�`���D�ؙ� v�1L<2��%��.џcY�l�\u0011��i��k>�ii�^�T�1�\u000f5ťA79Î\u0019��5��j�t ���O�)&�b�!���փ��ۉ2S��\\|�7&����g9O4Œ��´h/6ϟ}p���\u0001p� | `pages/reforms-index__15.html (http://www.nhmrc.gov.au/file/14281/download?token=yf_EGIEL)` |\n| $896.1\n, $828.8\n, $877.7\n, $783.3\n, $923.2\n, $760.2 | Results of NHMRC grant application rounds\nTable: Results of NHMRC grant application rounds\nPrevious application rounds\n2015\n2016\n2017\n2018\n2019\n2020\n1\n2021\n2022\n2023\n2024\n2025\nTotal commitments ($ million)\n$896.1\n$828.8\n$877.7\n$783.3\n$923.2\n$760.2\n$986.1\n$900.0\n$908.3\n$1,005.2\n$1,078.6\nTotal number of new grants\n1,132\n1,056\n1,103\n1,045\n857\n740\n777\n725\n686\n740\n715\n1\nCommitments in 2020 were lower than expected due to the delay of the Clinical Tria | `pages/strategies-index__02.html (http://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds)` |\n\n## Key Achievements\n\n- Health may, upon written notice to the Eligible Organisation, immediately take any of the\nactions specified in clause 16.2 if:\na. it reasonably considers that the Eligible Organisation or a Participating Institution\nhas failed to comply with a term or condition of this Agreement, the requirements\nof being an Eligible Organisation, the NHMRC Approved Standards and\nGuidelines or a Funding Policy;\nb. within the last 3 years a Specified Person or any other personnel working on a\nResearch Activity has been found to have engaged in proven Misconduct related\nto funding provided by Health or NHMRC;\nc. it reasonably considers that the Eligible Organisation or Specified Personnel have\nprovided Misleading Information, including in an Application or a Report;\nd. it reasonably considers that the purposes and activities of the Eligible\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 12]\na. has a material adverse effect on the integrity, character or honesty of the\nEligible Organisation, a Participating Institution or Personnel involved in a\nResearch Activity; or\nb. relates to the Eligible Organisation, a Participating Institution or Personnel\ninvolved in a Research Activity and has a material adverse effect on the\npublic interest or public confidence in the Eligible Organisation, Participating\nInstitution or Research Activity;\n\"Progress Report\" has the meaning given in clauses 10.18 and 10.19;\n\"Register of Eligible Organisations\" means the published list of organisations that\nhave been granted Eligible Organisation status on NHMRC’s website.\n\"Reports\" means all of the reports, statements and acquittals described in clause 10;\n\"Research Activity\" means an activity that is Funded under a Scheme and which is\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 25,26,27,28,29,30]\nccess eProtocol\n(c) set a secure password for eProtocol (i.e. combination of upper\nand lower case letters, numbers and symbols) and change as\ninstructed\n(d) limit disclosure of the password to Bellberry staff\n(e) where operating systems and internet browsers automatically\ncreate a download of documents upon opening and save these to\nthe desktop or a download folder, ensure that automatically saved\ndocuments are securely deleted and the trash emptied at the close\nof each user session\n(f) sign out of eProtocol when a session has been finished\n(g) keep any relevant computer software, personal firewall and\nantivirus protection up to date\n(h) comply with any other IT security policy as determined by\nBellberry.\n Source: `reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)`\n- NHMRC expenditure by Former National Health Priority Areas 2016 to 2025\nFormer National Health Priority Areas\n2016\n$ million\n2017\n$ million\n2018\n$ million\n2019\n$ million\n2020\n$ million\n2021\n$ million\n2022\n$ million\n2023\n$ million\n2024\n$ million\n2025\n$ million\nArthritis and Osteoporosis\n19.3\n18.9\n17.5\n18.3\n16.1\n14.8\n16\n16.9\n17.8\n20.0\nAsthma\n15.3\n13.3\n15.7\n13.8\n13.3\n14.1\n12.5\n11.8\n9.2\n8.3\nCancer\n170.6\n175.8\n178.9\n181.6\n170.2\n153.7\n158.9\n165.6\n164.7\n186.0\nCardiovascular Disease\n114.9\n111.4\n105.3\n112.6\n107.6\n102.5\n97.5\n93.1\n88.8\n87.8\nDementia\n1\n45.6\n50.2\n60.9\n71.2\n64.1\n55.3\n51.5\n44.2\n38.8\n39.7\nDiabetes\n65.0\n57.7\n50.7\n46.5\n45.6\n42.6\n42.3\n41.4\n34.1\n30.0\nInjury\n45.8\n44.2\n49.9\n51.1\n49.8\n46.6\n49.8\n49.2\n48.8\n56.1\nMental Health\n2\n91.1\n93.4\n104.9\n110.2\n103.9\n102.3\n100.8\n105.5\n102.8\n119.1\nObesity\n28.1\n27.6\n23.0\n23.5\n24.3\n23.1\n20\n18.4\n16\n16.2\n1\n Source: `pages/strategies-index__04.html (http://www.nhmrc.gov.au/funding/outcomes-and-data-research/research-funding-statistics-and-data)`\n- State of the Region 2019: Health Security in the Indo-Pacific.\nhttps://indopacifichealthsecurity.dfat.gov.au/sites/default/files/2022-07/Indo-Pacific%20Health%20Security%20-%20State%20of%20the%20Region%202019.pdf\n4\nGlobal Research on Antimicrobial Resistance, 'Global burden of bacterial AMR'\nhttps://www.tropicalmedicine.ox.ac.uk/gram/research/global-burden-of-bacterial-antimicrobial-resistance\n5\nWorld Health Organization, 'WHO Strategic Priorities on Antimicrobial Resistance'\n6\nLow et al (2015) Non-communicable diseases in the Asia-Pacific region: Prevalence, risk factors and community-based prevention.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- 16\nClimate Change: an urgent health priority (April 2022)\nhttps://aahms.org/wp-content/uploads/2022/06/Health-impacts-of-climate-change.pdf\n17\nhttps://www.nhmrc.gov.au/about-us/news-centre/which-treatments-will-save-lives-icu\n18\nCSIRO Futures (2022) Strengthening Australia’s Pandemic Preparedness: Science and technology enabled solutions.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 10]\nlayouts and all other rights resulting from intellectual activity in the industrial, scientific,\nliterary or artistic fields but excludes Moral Rights and rights in relation to Confidential\nInformation;\n\"Interest\" (in clauses 8.11, 15.2 and 16.6) means interest calculated at an interest\nrate equal to the 90 day bank-accepted bill rate (available from the Reserve Bank of\nAustralia) less 10 basis points, on a daily compounding basis;\n\"Material\" means anything in relation to which Intellectual Property rights arise;\n“Misconduct” includes Research Misconduct and fraudulent conduct.\n\"Misleading Information\" includes, but is not limited to, information that:\na. is false, including making a false claim in relation to a publication record\n(e.g. describing a paper as being ‘in press’ or ‘accepted’ if it has only been\nsubmitted);\nb.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 12,13,14]\nion to be accountable for the administration of the Funds, the\nconduct of a Research Activity or other matter;\n\"Salary Support Package\" means, in respect of a Research Activity, the Funds for\nthe salaries or Stipends and related costs of the Research Activity's Personnel\nidentified in the Approved Budget for the Research Activity;\n\"Schedule\" means a document signed by the Parties (including in accordance with\nclauses 2.3 and 4), which is substantially in the form of, and contains the information\nrequired by, the template provided by Health and includes any attachment to the\nSchedule;\n\"Scheme\" means a funding scheme or grant opportunity administered by NHMRC\nand funded by the MRFF, including:\na. a Research Support Scheme;\nb. a People Support Scheme; and\nc. any Other Scheme;\nPage 11 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 34]\ni. the Eligible Organisation or a Participating Institution becomes unable to pay all its\ndebts as and when they become due and payable;\nj. the Eligible Organisation or a Participating Institution has applied to come under,\nreceived a notice requiring it to show cause why it should not come under, or has\notherwise come under one of the forms of external administration referred to in\nChapter 5 of the Corporations Act 2001 (Cth) or equivalent provisions in\nlegislation of the States and Territories pertaining to incorporated associations or\nChapter 11 of the Corporations (Aboriginal and Torres Strait Islander) Act 2006\n(Cth) or an order has been made for the purpose of placing the Eligible\nOrganisation or a Participating Institution under external administration;\nk. the Eligible Organisation or a Participating Institution undergoes a Change of\nControl;\nl.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 46]\nf. it or a Participating Institution has applied to come under, received a notice\nrequiring it to show cause why it should not come under, or has otherwise come\nunder one of the forms of external administration referred to in Chapter 5 of the\nCorporations Act 2001 (Cth) or equivalent provisions in legislation of the States\nand Territories pertaining to incorporated associations or Chapter 11 of the\nCorporations (Aboriginal and Torres Strait Islander) Act 2006 (Cth) or an order\nhas been made for the purpose of placing the Eligible Organisation or\nParticipating Institution under external administration;\ng. it or a Participating Institution undergoes a Change of Control;\nh. it becomes aware of a Probity Event, or a Conflict of Interest;\ni. it becomes aware of any delay of six months or more that is likely to occur in\nrelation to the performance of a Research Activity;\nj.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report\n Source: `pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)`\n\n## Key Issues, Risks, and Recommendations\n\n- State of the Region 2019: Health Security in the Indo-Pacific.\nhttps://indopacifichealthsecurity.dfat.gov.au/sites/default/files/2022-07/Indo-Pacific%20Health%20Security%20-%20State%20of%20the%20Region%202019.pdf\n4\nGlobal Research on Antimicrobial Resistance, 'Global burden of bacterial AMR'\nhttps://www.tropicalmedicine.ox.ac.uk/gram/research/global-burden-of-bacterial-antimicrobial-resistance\n5\nWorld Health Organization, 'WHO Strategic Priorities on Antimicrobial Resistance'\n6\nLow et al (2015) Non-communicable diseases in the Asia-Pacific region: Prevalence, risk factors and community-based prevention.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- [Page 46]\nf. it or a Participating Institution has applied to come under, received a notice\nrequiring it to show cause why it should not come under, or has otherwise come\nunder one of the forms of external administration referred to in Chapter 5 of the\nCorporations Act 2001 (Cth) or equivalent provisions in legislation of the States\nand Territories pertaining to incorporated associations or Chapter 11 of the\nCorporations (Aboriginal and Torres Strait Islander) Act 2006 (Cth) or an order\nhas been made for the purpose of placing the Eligible Organisation or\nParticipating Institution under external administration;\ng. it or a Participating Institution undergoes a Change of Control;\nh. it becomes aware of a Probity Event, or a Conflict of Interest;\ni. it becomes aware of any delay of six months or more that is likely to occur in\nrelation to the performance of a Research Activity;\nj.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- Results of NHMRC grant application rounds\nTable: Results of NHMRC grant application rounds\nPrevious application rounds\n2015\n2016\n2017\n2018\n2019\n2020\n1\n2021\n2022\n2023\n2024\n2025\nTotal commitments ($ million)\n$896.1\n$828.8\n$877.7\n$783.3\n$923.2\n$760.2\n$986.1\n$900.0\n$908.3\n$1,005.2\n$1,078.6\nTotal number of new grants\n1,132\n1,056\n1,103\n1,045\n857\n740\n777\n725\n686\n740\n715\n1\nCommitments in 2020 were lower than expected due to the delay of the Clinical Trials and Cohort Studies Grant round and Synergy Grant rounds impacted by COVID-19.\n Source: `pages/strategies-index__02.html (http://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds)`\n- The NHMRC–AMED 2022 Dementia Collaborative Research Scheme invites applications for research on the many potential causes of dementia and modifiable lifestyle risk and protective factors that may prevent or delay the onset of dementia.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- [pages 25,26,27,28,29,30]\nccess eProtocol\n(c) set a secure password for eProtocol (i.e. combination of upper\nand lower case letters, numbers and symbols) and change as\ninstructed\n(d) limit disclosure of the password to Bellberry staff\n(e) where operating systems and internet browsers automatically\ncreate a download of documents upon opening and save these to\nthe desktop or a download folder, ensure that automatically saved\ndocuments are securely deleted and the trash emptied at the close\nof each user session\n(f) sign out of eProtocol when a session has been finished\n(g) keep any relevant computer software, personal firewall and\nantivirus protection up to date\n(h) comply with any other IT security policy as determined by\nBellberry.\n Source: `reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)`\n- [Page 39]\nComment\nEligibility criteria\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nSample size Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nStatistical analysis plan Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nData management plan Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nRisk profile (protocol) Comment\n☐ Appropriate\nPage 40 of 41\n Source: `reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)`\n- By 1990, it was estimated that there were over 100 IECs throughout Australia and in 2005, there are more than 220. (IECs are now known as Human Research Ethics Committees.)\nThe\nNational Health and Medical Research Council Act 1992\nestablishes the Role of the CEO whose functions include the issue of \"guidelines for the conduct of medical research involving humans\".\n Source: `pages/announcements-index__22.html (http://www.nhmrc.gov.au/research-policy/ethics/national-statement-ethical-conduct-human-research)`\n- NHMRC expenditure by Former National Health Priority Areas 2016 to 2025\nFormer National Health Priority Areas\n2016\n$ million\n2017\n$ million\n2018\n$ million\n2019\n$ million\n2020\n$ million\n2021\n$ million\n2022\n$ million\n2023\n$ million\n2024\n$ million\n2025\n$ million\nArthritis and Osteoporosis\n19.3\n18.9\n17.5\n18.3\n16.1\n14.8\n16\n16.9\n17.8\n20.0\nAsthma\n15.3\n13.3\n15.7\n13.8\n13.3\n14.1\n12.5\n11.8\n9.2\n8.3\nCancer\n170.6\n175.8\n178.9\n181.6\n170.2\n153.7\n158.9\n165.6\n164.7\n186.0\nCardiovascular Disease\n114.9\n111.4\n105.3\n112.6\n107.6\n102.5\n97.5\n93.1\n88.8\n87.8\nDementia\n1\n45.6\n50.2\n60.9\n71.2\n64.1\n55.3\n51.5\n44.2\n38.8\n39.7\nDiabetes\n65.0\n57.7\n50.7\n46.5\n45.6\n42.6\n42.3\n41.4\n34.1\n30.0\nInjury\n45.8\n44.2\n49.9\n51.1\n49.8\n46.6\n49.8\n49.2\n48.8\n56.1\nMental Health\n2\n91.1\n93.4\n104.9\n110.2\n103.9\n102.3\n100.8\n105.5\n102.8\n119.1\nObesity\n28.1\n27.6\n23.0\n23.5\n24.3\n23.1\n20\n18.4\n16\n16.2\n1\n Source: `pages/strategies-index__04.html (http://www.nhmrc.gov.au/funding/outcomes-and-data-research/research-funding-statistics-and-data)`\n- 10\nThe COVID-19 pandemic has brought the risks associated with multimorbidity into the spotlight as many of those who have experienced severe illness and death as a result of COVID-19 have had one or more underlying chronic conditions.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- 16\nClimate Change: an urgent health priority (April 2022)\nhttps://aahms.org/wp-content/uploads/2022/06/Health-impacts-of-climate-change.pdf\n17\nhttps://www.nhmrc.gov.au/about-us/news-centre/which-treatments-will-save-lives-icu\n18\nCSIRO Futures (2022) Strengthening Australia’s Pandemic Preparedness: Science and technology enabled solutions.\n Source: `pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)`\n- [Page 6]\nMRFXXXXXX\nH.1.4 In undertaking a risk assessment under Item H.1.3, the Eligible Organisation must have\nregard to:\n(a) the nature and circumstances of the offence(s) on the person’s Criminal or Court Record\nand whether the charge or conviction involved Vulnerable Persons;\n(b) whether the person’s Criminal or Court Record is directly relevant to, or reasonably\nlikely to impair the person’s ability to perform, the role that the person will, or is likely\nto, perform in relation to the Research Activity;\n(c) the length of time that has passed since the person’s charge or conviction and his or her\nrecord since that time;\n(d) the circumstances in which the person will, or is likely to, have contact with a Vulnerable\nPerson as part of the Research Activity;\n(e) any other relevant matter,\nand must ensure it fully documents the conduct and outcome of the risk assessment.\n Source: `other-pdfs/Example-20MRFF-20Grant-20Schedule-20Template.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Example%20MRFF%20Grant%20Schedule%20Template.pdf)`\n- For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 10]\nlayouts and all other rights resulting from intellectual activity in the industrial, scientific,\nliterary or artistic fields but excludes Moral Rights and rights in relation to Confidential\nInformation;\n\"Interest\" (in clauses 8.11, 15.2 and 16.6) means interest calculated at an interest\nrate equal to the 90 day bank-accepted bill rate (available from the Reserve Bank of\nAustralia) less 10 basis points, on a daily compounding basis;\n\"Material\" means anything in relation to which Intellectual Property rights arise;\n“Misconduct” includes Research Misconduct and fraudulent conduct.\n\"Misleading Information\" includes, but is not limited to, information that:\na. is false, including making a false claim in relation to a publication record\n(e.g. describing a paper as being ‘in press’ or ‘accepted’ if it has only been\nsubmitted);\nb.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 12,13,14]\nion to be accountable for the administration of the Funds, the\nconduct of a Research Activity or other matter;\n\"Salary Support Package\" means, in respect of a Research Activity, the Funds for\nthe salaries or Stipends and related costs of the Research Activity's Personnel\nidentified in the Approved Budget for the Research Activity;\n\"Schedule\" means a document signed by the Parties (including in accordance with\nclauses 2.3 and 4), which is substantially in the form of, and contains the information\nrequired by, the template provided by Health and includes any attachment to the\nSchedule;\n\"Scheme\" means a funding scheme or grant opportunity administered by NHMRC\nand funded by the MRFF, including:\na. a Research Support Scheme;\nb. a People Support Scheme; and\nc. any Other Scheme;\nPage 11 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n\n## Corporate Values and Operating Culture\n\n- Its findings provide a baseline for enhancing service delivery and effectiveness.\nmini-card, small-h-img\ntrue\nsec-spacing\nsection-none\nsec-spacing-bottom\nsection-padding-between\nstyle\ndefault\nCONNECT\nWITH US\nfalse\nX\nlp-x\nhttps://x.com/wbg_gov\nSubscribe to our monthly newsletter\nWorld Bank Governance Global Department\nThe latest news, publications, and events on institutions, good governance, GovTech, open government, procurement, anticorruption, public finance, accountability & more.\nfalse\nGovernance Update|SVC123\nfalse\nTopic Expert\nArturo Herrera\nhttps://www.worldbank.org/en/about/people/a/arturo-herrera-gutierrez\ndefault alt\nDirector, Governance Global Department, World Bank\nmini-card\nmini-card\nView All Experts\nGovernance Contact\nLara Saade\nlsaade@worldbank.org\nsec-swoosh\nsec-swoosh-type11\nstyle\ngrid, bg-neutrals-20, stay-connected\nsec-spacing\nsection-none\nsec-spacing-bottom\n Source: `global-intelligence/source-text/association-worldbank.org-governance.txt`\n- [Page 10]\nlayouts and all other rights resulting from intellectual activity in the industrial, scientific,\nliterary or artistic fields but excludes Moral Rights and rights in relation to Confidential\nInformation;\n\"Interest\" (in clauses 8.11, 15.2 and 16.6) means interest calculated at an interest\nrate equal to the 90 day bank-accepted bill rate (available from the Reserve Bank of\nAustralia) less 10 basis points, on a daily compounding basis;\n\"Material\" means anything in relation to which Intellectual Property rights arise;\n“Misconduct” includes Research Misconduct and fraudulent conduct.\n\"Misleading Information\" includes, but is not limited to, information that:\na. is false, including making a false claim in relation to a publication record\n(e.g. describing a paper as being ‘in press’ or ‘accepted’ if it has only been\nsubmitted);\nb.\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [pages 12,13,14]\nion to be accountable for the administration of the Funds, the\nconduct of a Research Activity or other matter;\n\"Salary Support Package\" means, in respect of a Research Activity, the Funds for\nthe salaries or Stipends and related costs of the Research Activity's Personnel\nidentified in the Approved Budget for the Research Activity;\n\"Schedule\" means a document signed by the Parties (including in accordance with\nclauses 2.3 and 4), which is substantially in the form of, and contains the information\nrequired by, the template provided by Health and includes any attachment to the\nSchedule;\n\"Scheme\" means a funding scheme or grant opportunity administered by NHMRC\nand funded by the MRFF, including:\na. a Research Support Scheme;\nb. a People Support Scheme; and\nc. any Other Scheme;\nPage 11 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report\n Source: `pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)`\n- Policies and procedures\nI declare that the institution/organisation has policies, procedures and training, staffing and\ninfrastructure in place to:\n• enable the employment of Chief Investigators (CIs) named on research grants funded by\nNHMRC\n• ensure that the institution/organisation maintains a high standard of research integrity\nand ethical governance in compliance with the Australian Code for the Responsible\nConduct of Research\n• meet NHMRC’s gender equity requirements, which include supporting the progression\nand retention of women in health and medical research\n• ensure the identification, declaration, management, and reporting to NHMRC of any\nConflicts of Interest\n• support research environments that are free from bias, discrimination and sexual or\nother harassment, and have procedures in place to fairly address any instances of such\nbehaviour\n Source: `other-pdfs/NHMRC-Administering--20Institution-Status-Application-Form-2.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Research%20Administration/NHMRC-Administering-%20Institution-Status-Application-Form-2.pdf)`\n- [pages 8,9,10]\nin respect of\nthe Participating Institution's conduct of its part of a Research Activity or Research\nActivities and the expenditure of some or all of the Funds (if any) provided to the\nParticipating Institution for that purpose.\n\"Funds\" or \"Funding\" has the same meaning as “Grant”;\n\"Funding Condition\" means a condition, standard or guideline specified in a\nSchedule (or an attachment to a Schedule), or imposed by Health, in respect of a\nResearch Activity and with which the Eligible Organisation is required to comply in\nrespect of that Research Activity;\n\"Funding Identification Number\" means, in respect of a Research Activity, the\nidentifying number specified in the Schedule for that Research Activity that was\noriginally assigned to the Application for that Research Activity;\nPage 7 31821071\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- [Page 12]\na. has a material adverse effect on the integrity, character or honesty of the\nEligible Organisation, a Participating Institution or Personnel involved in a\nResearch Activity; or\nb. relates to the Eligible Organisation, a Participating Institution or Personnel\ninvolved in a Research Activity and has a material adverse effect on the\npublic interest or public confidence in the Eligible Organisation, Participating\nInstitution or Research Activity;\n\"Progress Report\" has the meaning given in clauses 10.18 and 10.19;\n\"Register of Eligible Organisations\" means the published list of organisations that\nhave been granted Eligible Organisation status on NHMRC’s website.\n\"Reports\" means all of the reports, statements and acquittals described in clause 10;\n\"Research Activity\" means an activity that is Funded under a Scheme and which is\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)`\n- 3\nI Zucker and BJ Prendergast, ‘Sex differences in pharmacokinetics predict adverse drug reactions in women’,\nBiology of Sex Differences\n, 2020, 11(32), doi:10.1186/s13293-020-00308-5; M Frommer, J Howell, E Santow, S Cochrane and B Alston,\nEnsuring health and bodily integrity: towards a human rights approach for people born with variations in sex characteristics\n, Australian Human Rights Commission, Australian Government, 2021, accessed 26 September 2023.\n Source: `pages/announcements-index__23.html (http://www.nhmrc.gov.au/research-policy/gender-equity/statement-sex-and-gender-research)`\n\n## Global Ideas and Case Study Inputs\n\nGlobal source texts are available for later idea synthesis:\n- `global-intelligence/source-text/association-worldbank.org-governance.txt`\n- `global-intelligence/source-text/consulting-deloitte.com-government-public.txt`\n- `global-intelligence/source-text/university-ash.harvard.edu-Harvard-Kennedy-School-Ash-Center.txt`\n\n## Source Artifacts Used\n\n- `strategies/NHMRC_Gender_Equity_Strategy_FA.pdf` - strategies - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC_Gender_Equity_Strategy_FA.pdf\n- `strategies/International-Engagement-Strategy-2023-2026.pdf` - strategies - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf\n- `reviews/final-report-national-scientific-committees.pdf` - reviews - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf\n- `pages/about.html` - pages - http://www.nhmrc.gov.au/about-us\n- `pages/announcements-index.html` - pages - http://www.nhmrc.gov.au/about-us/news-centre/statement-ceos-arc-and-nhmrc-policy-use-generative-artificial-intelligence-grant-applications-and-assessment\n- `pages/announcements-index__16.html` - pages - https://www.nhmrc.gov.au/about-us/news-centre/statement-ceos-arc-and-nhmrc-policy-use-generative-artificial-intelligence-grant-applications-and-assessment\n- `pages/announcements-index__17.html` - pages - http://www.nhmrc.gov.au/about-us/news-centre/statement-ceos-arc-and-nhmrc-policy-use-generative-artificial-intelligence-grant-applications-and-assessment\n- `pages/announcements-index__18.html` - pages - https://www.nhmrc.gov.au/sites/default/files/images/NHMRC-ARC%20AI%20joint%20statement%20policy%20on%20use%20of%20generative%20AI%20in%20grant%20applications%20and%20assessment.pdf\n- `pages/announcements-index__19.html` - pages - http://www.nhmrc.gov.au/file/25005/download?token=fKs4KVQQ\n- `pages/announcements-index__20.html` - pages - http://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research/completed-consultation-activities\n- `pages/announcements-index__21.html` - pages - http://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research\n- `pages/announcements-index__22.html` - pages - http://www.nhmrc.gov.au/research-policy/ethics/national-statement-ethical-conduct-human-research\n- `pages/announcements-index__23.html` - pages - http://www.nhmrc.gov.au/research-policy/gender-equity/statement-sex-and-gender-research\n- `pages/announcements-index__24.html` - pages - http://www.nhmrc.gov.au/research-policy/research-priorities/nhmrc-health-priorities\n- `pages/homepage.html` - pages - http://www.nhmrc.gov.au\n- `pages/leadership.html` - pages - http://www.nhmrc.gov.au/about-us/leadership-and-governance\n- `pages/ministers.html` - pages - http://www.nhmrc.gov.au/funding/manage-your-funding/nhmrc-funding/administering-institutions\n- `pages/news-latest.html` - pages - http://www.nhmrc.gov.au/about-us/news-centre\n- `pages/publications-index.html` - pages - http://www.nhmrc.gov.au/about-us/publications\n- `pages/reforms-index.html` - pages - http://www.nhmrc.gov.au/research-policy/clinical-trial-reform\n- `pages/reforms-index__13.html` - pages - https://www.nhmrc.gov.au/research-policy/clinical-trial-reform\n- `pages/reforms-index__14.html` - pages - http://www.nhmrc.gov.au/research-policy/clinical-trial-reform\n- `pages/reforms-index__15.html` - pages - http://www.nhmrc.gov.au/file/14281/download?token=yf_EGIEL\n- `pages/strategies-index.html` - pages - http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities\n- `pages/strategies-index__00.html` - pages - https://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities\n- `pages/strategies-index__01.html` - pages - http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities\n- `pages/strategies-index__02.html` - pages - http://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds\n- `pages/strategies-index__03.html` - pages - http://www.nhmrc.gov.au/funding/outcomes-and-data-research\n- `pages/strategies-index__04.html` - pages - http://www.nhmrc.gov.au/funding/outcomes-and-data-research/research-funding-statistics-and-data\n- `pages/strategies-index__05.html` - pages - http://www.nhmrc.gov.au/node/8218\n- `pages/strategies-index__06.html` - pages - http://www.nhmrc.gov.au/node/8221\n- `pages/strategies-index__07.html` - pages - http://www.nhmrc.gov.au/file/17581/download?token=IkDPKyub\n- `pages/strategies-index__08.html` - pages - http://www.nhmrc.gov.au/file/18407/download?token=_nLJwZKB\n- `pages/strategies-index__09.html` - pages - http://www.nhmrc.gov.au/funding/data-research/outcomes\n- `pages/strategies-index__10.html` - pages - http://www.nhmrc.gov.au/funding/outcomes-and-data-research/data-dictionary-and-data-glossary\n- `pages/strategies-index__11.html` - pages - http://www.nhmrc.gov.au/research-policy/gender-equity/nhmrc-gender-equity-strategy\n- `pages/strategies-index__12.html` - pages - http://www.nhmrc.gov.au/research-policy/research-priorities/framework-identifying-and-prioritising-targeted-calls-research\n- `pages/structure.html` - pages - http://www.nhmrc.gov.au/funding/manage-your-funding/mrff-funding/mrff-eligible-organisations\n- `global-intelligence/source-text/association-worldbank.org-governance.txt` - global-intelligence - local file\n- `global-intelligence/source-text/consulting-deloitte.com-government-public.txt` - global-intelligence - local file\n- `global-intelligence/source-text/university-ash.harvard.edu-Harvard-Kennedy-School-Ash-Center.txt` - global-intelligence - local file\n- `other-pdfs/Example-20MRFF-20Grant-20Schedule-20Template.pdf` - other-pdfs - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Example%20MRFF%20Grant%20Schedule%20Template.pdf\n- `other-pdfs/NHMRC-ARC-20AI-20joint-20statement-20policy-20on-20use-20of-20generative-20AI-20.pdf` - other-pdfs - https://www.nhmrc.gov.au/sites/default/files/images/NHMRC-ARC%20AI%20joint%20statement%20policy%20on%20use%20of%20generative%20AI%20in%20grant%20applications%20and%20assessment.pdf\n- `other-pdfs/NHMRC-Administering--20Institution-Status-Application-Form-2.pdf` - other-pdfs - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Research%20Administration/NHMRC-Administering-%20Institution-Status-Application-Form-2.pdf\n- `other-pdfs/NHMRC-Approved-Administering-Institutions.pdf` - other-pdfs - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC-Approved-Administering-Institutions.pdf\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf` - other-pdfs - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf\n\n## Gaps To Fix\n\n- No corporate plan text source found.\n- No annual report text source found.", "legislation_md": "# National Health and Medical Research Council - Acts and Legislation Discovery\n\n**Generated at**: 2026-05-09T20:53:09.409256+00:00\n**Entity ID**: O-000876\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n\n> This is an evidence-based discovery list from scraped department material. A mention does not always mean the department administers the legislation; high-confidence and official register links should be reviewed.\n\n## Summary\n\n- Source files scanned: 43\n- Unique legislation references found: 17\n\n| Type | Count |\n|---|---:|\n| Act | 17 |\n\n## Legislation References\n\n### Medical Research Future Fund Act 2015\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Medical+Research+Future+Fund+Act+2015\n\n**Sources**:\n- `pages/structure.html`\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- come an MRFF EO is managed by the grant hub administering the relevant MRFF funding – that is, NHMRC or the Business Grants Hub (BGH). This page outlines the process for obtaining EO status to apply for MRFF funding administered by NHMRC.\nThe objective of the\nMedical Research Future Fund Act 2015\nis to improve the health and wellbeing of Australians. The role of an MRFF EO is to support this objective by undertaking medical research and medical innovation activities in accordance with the terms and conditions set out in any MRFF Funding Agreement to w\n Source: `pages/structure.html`\n- New Tax System (Australian\nBusiness Number) Act 1999 (Cth);\n\"Account\" means the Medical Research Future Fund Health Special Account\nestablished under section 23 of the Act;\n\"Acquittal Statement\" has the meaning given in clauses 10.11 to 10.14;\n\"Act\" means the Medical Research Future Fund Act 2015 (Cth);\n“Additional Report” has the meaning given in clause 10.24;\n\"Agreement\" means this deed once it is executed by both Parties and includes the\nSchedules and any attachments or annexures as may be amended from time to time;\n\"Annual Financial Statement\" has\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### National Health Act 1953\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=National+Health+Act+1953\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- ___________________________________________ 46\nPage iii 31821071\n\n[page 4]\nTHIS AGREEMENT is made on the………. day of .............................. 2025\nBETWEEN THE\nCOMMONWEALTH OF AUSTRALIA (the Commonwealth) as represented by\nthe Minister who administers the National Health Act 1953 (Cth) or his or her\ndelegate (ABN 83 605 426 759)\nAND\n (the Eligible Organisation)\nACN or ABN: XX XXX XXX XXX\nOf:
\nWHEREAS:\nA. The Medical Research Future Fund Act 2015 (the Act) provides for the establishment of\nth\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n- the Health Minister has delegated his or her power under section 27 of the Act\nto enter into agreements for the provision of Funding in accordance with s61A of the\nAct;\n“Health Minister” means the Commonwealth Minister who, from time to time,\nadministers the National Health Act 1953 (Cth) or his or her delegate under s61A of\nthe Act;\n\"Incorporated Material\" means, in respect of a Research Activity, Existing Material\nthat is incorporated in, supplied with (or as part of), or required to be supplied with (or\nas part of), the Research Mater\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### National Health and Medical Research Council Act 1992\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=National+Health+and+Medical+Research+Council+Act+1992\n\n**Sources**:\n- `pages/strategies-index__10.html`\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- e may vary from the actual funds paid to Administering Institutions due to indexation of payments and other post award funding variations. Figures are typically GST exclusive.\nM\nMedical Research Endowment Account (MREA)\nA Special Account established under the\nNational Health and Medical Research Council Act 1992\n(NHMRC Act). The MREA is funded through government appropriations, which are allocated annually in the Federal Budget. These funds are transferred to the MREA to support research activities that align with the objectives of NHMRC's schemes and grant opportuni\n Source: `pages/strategies-index__10.html`\n- means the Medical Research Future Fund established under the Act ;\n\"NHMRC\" means the Commonwealth of Australia acting through the National Health\nand Medical Research Council ABN 88 601 010 284 established by section 5B of the\nNHMRC Act;\n\"NHMRC Act\" means the National Health and Medical Research Council Act 1992\n(Cth);\n\"NHMRC Approved Standards and Guidelines\" are those listed as such on the\nNHMRC website and include, but are not limited to, the:\na. Australian Code for the Responsible Conduct of Research (2018);\nb. Australian code for the care and use of animals for\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### A. The Medical Research Future Fund Act 2015\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=A.+The+Medical+Research+Future+Fund+Act+2015\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- e Commonwealth) as represented by\nthe Minister who administers the National Health Act 1953 (Cth) or his or her\ndelegate (ABN 83 605 426 759)\nAND\n (the Eligible Organisation)\nACN or ABN: XX XXX XXX XXX\nOf:
\nWHEREAS:\nA. The Medical Research Future Fund Act 2015 (the Act) provides for the establishment of\nthe Medical Research Future Fund Special Account (MRFF Special Account) and the\nMedical Research Future Fund Health Special Account (the Account). Having regard to\nthe Australian Medical Research and Innovation Prio\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### Human Research Ethics Committees.) The National Health and Medical Research Council Act 1992\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Human+Research+Ethics+Committees.%29+The+National+Health+and+Medical+Research+Council+Act+1992\n\n**Sources**:\n- `pages/announcements-index__22.html`\n\n**Evidence contexts**:\n- uncil. The risk of ineligibility to receive Council funds was an effective inducement for institutions to establish IECs. By 1990, it was estimated that there were over 100 IECs throughout Australia and in 2005, there are more than 220. (IECs are now known as Human Research Ethics Committees.)\nThe\nNational Health and Medical Research Council Act 1992\nestablishes the Role of the CEO whose functions include the issue of \"guidelines for the conduct of medical research involving humans\". These guidelines must be issued precisely as developed by the principal committee of Council known as the\nAustralian Health\n Source: `pages/announcements-index__22.html`\n\n### Medical Research Endowment Fund Act 1937\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Medical+Research+Endowment+Fund+Act+1937\n\n**Sources**:\n- `pages/announcements-index__22.html`\n\n**Evidence contexts**:\n- RC consultations\n. Public consultations are advertised in the\nNHMRC Tracker\n.\nHistory\nAustralian activity in ethical review of human research began during the 1960s and was related closely to the federal funding of medical research. Through the passage of the\nMedical Research Endowment Fund Act 1937\n, the Commonwealth Parliament had established the Medical Research Endowment Fund. Responsibility for the fund was vested in the Minister for Health, who could determine its use for medical research and in the training of persons in medical research, acting o\n Source: `pages/announcements-index__22.html`\n\n### Under the National Health and Medical Research Council Act 1992\n\n**Type**: Act\n**Confidence**: medium\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Under+the+National+Health+and+Medical+Research+Council+Act+1992\n\n**Sources**:\n- `pages/announcements-index__24.html`\n\n**Evidence contexts**:\n- Health priorities 2024–2027 | NHMRC\n\nThe major national health issues outlined below are NHMRC's health priorities for the 2024–2027 triennium.\nUnder the\nNational Health and Medical Research Council Act 1992\n, the CEO is required to identify major national health issues likely to arise in the coming year and beyond.\nNHMRC reviews its priorities every three years. In identifying health priorities, the CEO takes into consideration other Australian Government priori\n Source: `pages/announcements-index__24.html`\n\n### Australian Securities and Investments Commission Act 2001\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Australian+Securities+and+Investments+Commission+Act+2001\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- tatement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Ct\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n- the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;\n\"Bank\" means an authorised deposit-taking institution authorised to carry on banking\nbusiness in Australia under the Banking Act 1959\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### Corporations (Aboriginal and Torres Strait Islander) Act 2006\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Corporations+%28Aboriginal+and+Torres+Strait+Islander%29+Act+2006\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- come under one of the forms of external administration referred to in\nChapter 5 of the Corporations Act 2001 (Cth) or equivalent provisions in\nlegislation of the States and Territories pertaining to incorporated associations or\nChapter 11 of the Corporations (Aboriginal and Torres Strait Islander) Act 2006\n(Cth) or an order has been made for the purpose of placing the Eligible\nOrganisation or a Participating Institution under external administration;\nk. the Eligible Organisation or a Participating Institution undergoes a Change of\nControl;\nl. another provision\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n- come\nunder one of the forms of external administration referred to in Chapter 5 of the\nCorporations Act 2001 (Cth) or equivalent provisions in legislation of the States\nand Territories pertaining to incorporated associations or Chapter 11 of the\nCorporations (Aboriginal and Torres Strait Islander) Act 2006 (Cth) or an order\nhas been made for the purpose of placing the Eligible Organisation or\nParticipating Institution under external administration;\ng. it or a Participating Institution undergoes a Change of Control;\nh. it becomes aware of a Probity Event, or a C\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### New Tax System (Goods and Services Tax) Act 1999\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=New+Tax+System+%28Goods+and+Services+Tax%29+Act+1999\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- any requirements specified on the NHMRC or Health website, as amended\nby Health or NHMRC from time to time and to the extent that they are not inconsistent\nwith the terms of this Agreement;\n\"Government Related Entity\" has the meaning used in A New Tax System (Goods\nand Services Tax) Act 1999 (Cth) as in force and amended from time to time;\n\"Grant\" means, in respect of a Research Activity, the money, or any part of it, payable\nby the NHMRC to the Eligible Organisation for the Research Activity as specified in the\nFunding Agreement, and includes an\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n- ctivity as specified in the\nFunding Agreement, and includes any interest earned by the Eligible Organisation on\nthat money once the Grant has been paid to the Eligible Organisation.\n\"GST\" has the meaning given in the GST Act;\n\"GST Act\" means A New Tax System (Goods and Services Tax) Act 1999 (Cth);\n\"Health\" means the Commonwealth acting through the Department of Health,\nDisability and Aging ABN 83 605 426 759 and pursuant to clause 4, includes a\nreference to NHMRC;\n“Health Delegate” means an SES (Senior Executive Service) officer within Health to\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### Sex Discrimination Act 1984\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Sex+Discrimination+Act+1984\n\n**Sources**:\n- `pages/strategies-index__11.html`\n- `strategies/NHMRC_Gender_Equity_Strategy_FA.pages.jsonl`\n\n**Evidence contexts**:\n- research teams and research, including research participants.\nStrengthen guidance and training for peer reviewers to consider track record relative to opportunity, including career disruptions and circumstances.\nContinue to apply special measures\n2\nunder the\nSex Discrimination Act 1984\nto facilitate gender equity in the grant program, until the data demonstrates they are no longer required.\nKPI: Improved gender equity in the research and researchers NHMRC funds.\nPriority 2: Evidence and transparency about gender equity\nGoal: NHMRC actions a\n Source: `pages/strategies-index__11.html`\n- and researchers\nprogram and medical research. 9 Strengthen guidance and training for peer reviewers to consider track record relative NHMRC funds.\nto opportunity, including career disruptions and circumstances.\n9 Continue to apply special measures2 under the Sex Discrimination Act 1984 to facilitate\ngender equity in the grant program, until the data demonstrates they are no longer required.\n2. E vidence and NHMRC actions and 9 Maintain or strengthen transparency in reporting on NHMRC grant applications and Transparent data are\ntransparency\n Source: `strategies/NHMRC_Gender_Equity_Strategy_FA.pages.jsonl`\n\n### Under the Sex Discrimination Act 1984\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 2\n**Register search**: https://www.legislation.gov.au/search?query=Under+the+Sex+Discrimination+Act+1984\n\n**Sources**:\n- `pages/strategies-index__11.html`\n- `strategies/NHMRC_Gender_Equity_Strategy_FA.pages.jsonl`\n\n**Evidence contexts**:\n- clusion in the health and medical research sector.\n1\nGender inclusive refers to creating environments where people of any gender identity feel acknowledged and valued, including women and men, cis- and trans-gender, and non-binary and gender diverse people.\n2\nUnder the\nSex Discrimination Act 1984\n, special measures refer to positive actions taken with the purpose of achieving substantive equality.\n Source: `pages/strategies-index__11.html`\n- Raise the profile of gender positive role models.\n1 Gender inclusive refers to creating environments where people of any gender identity feel acknowledged and valued, including women and men, cis- and trans-gender, and non-binary and gender diverse people.\n2 Under the Sex Discrimination Act 1984, special measures refer to positive actions taken with the purpose of achieving substantive equality.\nNHMRC acknowledges the Traditional Custodians of country throughout Australia, and their continuing connection to land, sea and community. We pay our respect\n Source: `strategies/NHMRC_Gender_Equity_Strategy_FA.pages.jsonl`\n\n### Australian Information Commissioner Act 2010\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Australian+Information+Commissioner+Act+2010\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- , Existing Material\nthat is incorporated in, supplied with (or as part of), or required to be supplied with (or\nas part of), the Research Material for that Research Activity;\n\"Information Commissioner\" means any of the information officers appointed under\nthe Australian Information Commissioner Act 2010 (Cth) when exercising the privacy\nfunctions set out in section 9 of that Act or, if that Act is repealed, the Commonwealth\nofficer exercising similar functions;\n\"Infrastructure Support\" means the provision of any funding by Health for research\nactivities that\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### Higher Education Support Act 2003\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Higher+Education+Support+Act+2003\n\n**Sources**:\n- `pages/structure.html`\n\n**Evidence contexts**:\n- titutes – that is, bodies that conduct medical research as a primary purpose, and which are also registered with the Australian Charities and Not-for-Profits Commission\nUniversities – that is, Australian universities listed in either Table A or Table B of the\nHigher Education Support Act 2003\ncorporate Commonwealth entities – that is, Commonwealth entities that are bodies corporate\ncorporations – that is, Australian public companies, Australian private companies, and other incorporated entities.\nIf your organisation does not meet the requirements\n Source: `pages/structure.html`\n\n### New Tax System (Australian Business Number) Act 1999\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=New+Tax+System+%28Australian+Business+Number%29+Act+1999\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- o Health, and obtaining approvals\nfrom Health as required under this Agreement.\nIT IS HEREBY AGREED AS FOLLOWS:\n1. Definitions\n1.1. In this Agreement, unless the contrary intention appears:\n\"ABN\" has the meaning as given in section 41 of the A New Tax System (Australian\nBusiness Number) Act 1999 (Cth);\n\"Account\" means the Medical Research Future Fund Health Special Account\nestablished under section 23 of the Act;\n\"Acquittal Statement\" has the meaning given in clauses 10.11 to 10.14;\n\"Act\" means the Medical Research Future Fund Act 2015 (Cth);\n“Additi\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### Not-for-profit Sector Freedom to Advocate Act 2013\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Not-for-profit+Sector+Freedom+to+Advocate+Act+2013\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- or its Personnel in any activity referred to in clause 21.5.a.\n21.6. Nothing in clause 21.5 limits or derogates from the Eligible Organisation's obligations,\narising under this Agreement or otherwise, to not disclose confidential information as\ndefined in the Not-for-profit Sector Freedom to Advocate Act 2013 (Cth) or Personal\nInformation.\n22. Use of Information\n22.1. If any agency or body of the Commonwealth receives information from the Eligible\nOrganisation in relation to the Research Activity, the Eligible Organisation consents to that\nagency or body providing\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n### Part III of the Privacy Act 1988\n\n**Type**: Act\n**Confidence**: low\n**Mentions**: 1\n**Register search**: https://www.legislation.gov.au/search?query=Part+III+of+the+Privacy+Act+1988\n\n**Sources**:\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n**Evidence contexts**:\n- ection of Personal Information\n26.1. The Eligible Organisation agrees, in conducting the Research Activity:\na. not to do any act or engage in any practice which, if done or engaged in by the\nCommonwealth, would be a breach of the requirements of Division 2 of Part III of\nthe Privacy Act 1988 (Cth);\nb. ensure that any person under the control of the Eligible Organisation who has\naccess to any Personal Information is made aware of, and undertakes in writing,\nto observe the Eligible Organisation’s obligations under this clause 26;\nc. to comply with\n Source: `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl`\n\n## Files Scanned\n\n- `pages/about.html` (page)\n- `pages/announcements-index.html` (page)\n- `pages/announcements-index__16.html` (page)\n- `pages/announcements-index__17.html` (page)\n- `pages/announcements-index__18.html` (page)\n- `pages/announcements-index__19.html` (page)\n- `pages/announcements-index__20.html` (page)\n- `pages/announcements-index__21.html` (page)\n- `pages/announcements-index__22.html` (page)\n- `pages/announcements-index__23.html` (page)\n- `pages/announcements-index__24.html` (page)\n- `pages/homepage.html` (page)\n- `pages/leadership.html` (page)\n- `pages/ministers.html` (page)\n- `pages/news-latest.html` (page)\n- `pages/publications-index.html` (page)\n- `pages/reforms-index.html` (page)\n- `pages/reforms-index__13.html` (page)\n- `pages/reforms-index__14.html` (page)\n- `pages/reforms-index__15.html` (page)\n- `pages/strategies-index.html` (page)\n- `pages/strategies-index__00.html` (page)\n- `pages/strategies-index__01.html` (page)\n- `pages/strategies-index__02.html` (page)\n- `pages/strategies-index__03.html` (page)\n- `pages/strategies-index__04.html` (page)\n- `pages/strategies-index__05.html` (page)\n- `pages/strategies-index__06.html` (page)\n- `pages/strategies-index__07.html` (page)\n- `pages/strategies-index__08.html` (page)\n- `pages/strategies-index__09.html` (page)\n- `pages/strategies-index__10.html` (page)\n- `pages/strategies-index__11.html` (page)\n- `pages/strategies-index__12.html` (page)\n- `pages/structure.html` (page)\n- `other-pdfs/Example-20MRFF-20Grant-20Schedule-20Template.pages.jsonl` (pdf_pages)\n- `other-pdfs/NHMRC-Administering--20Institution-Status-Application-Form-2.pages.jsonl` (pdf_pages)\n- `other-pdfs/NHMRC-Approved-Administering-Institutions.pages.jsonl` (pdf_pages)\n- `other-pdfs/NHMRC-ARC-20AI-20joint-20statement-20policy-20on-20use-20of-20generative-20AI-20.pages.jsonl` (pdf_pages)\n- `other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pages.jsonl` (pdf_pages)\n- `reviews/final-report-national-scientific-committees.pages.jsonl` (pdf_pages)\n- `strategies/International-Engagement-Strategy-2023-2026.pages.jsonl` (pdf_pages)\n- `strategies/NHMRC_Gender_Equity_Strategy_FA.pages.jsonl` (pdf_pages)", "global_initiatives_md": "# Global Ideas Input - National Health and Medical Research Council\n\nUse the source text files in this folder to produce implementable ideas for Australia.\n\nFor each idea, separate:\n- large structural reforms\n- small/cheap operational changes\n- overseas case-study evidence\n- university/research support\n- consulting/association trend support\n- implementation steps in the Australian context\n- risks, prerequisites, and likely owner\n\n## Sources\n\n- [association] World Bank Governance Global Practice - https://www.worldbank.org/en/topic/governance - `source-text/association-worldbank.org-governance.txt`\n- [consulting] Deloitte Government and Public Services - https://www.deloitte.com/global/en/Industries/government-public.html - `source-text/consulting-deloitte.com-government-public.txt`\n- [university] Harvard Kennedy School Ash Center - https://ash.harvard.edu/ - `source-text/university-ash.harvard.edu-Harvard-Kennedy-School-Ash-Center.txt`", "strategy": { "reporting_period": "2024-25", "corporate_plan_period": "2025-26", "vision": "Vision: Australian health and medical researchers collaborate internationally to improve the health of the Australian community, our region and the world.", "vision_source_page": 1, "purposes": "Mission: To foster Australian participation in international networks and collaborative health and medical research.", "purposes_source_page": 1, "how_we_deliver": "How we deliver: Collaborate with international funding partners on opportunities to address shared health priorities and build regional capacity.", "how_we_deliver_source_page": 1, "government_priorities": [ { "text": "Priority 1: Collaboration in the Indo-Pacific region priorities and research impact", "source_page": 1 }, { "text": "Priority 2: Shared global health research priorities", "source_page": 1 }, { "text": "Priority 3: Researcher capability", "source_page": 1 }, { "text": "Priority 4: International networks", "source_page": 1 } ], "outcomes": [ { "name": "Outcome 1: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research", "description": "NHMRC grants support Australian researchers to collaborate internationally to enhance their expertise, capabilities and networks.", "key_activities": [ "Engage in targeted funding opportunities to support regional capacity building", "Participate in global organisations and multilateral alliances that foster collaboration on global health issues" ], "source_page": 1 } ], "values": [ "Transnational leadership and cooperation", "Information sharing", "Collaboration", "Sustainability", "Data sharing", "Open science" ], "values_framework_name": "International Engagement Strategy", "kpi_targets_2025_26": [ { "code": "CCE01", "measure": "The proportion of NHMRC grants with international collaborators", "target": "Increased", "source_page": 1 } ], "kpi_results_2024_25": [ { "code": "CCE01", "measure": "The proportion of NHMRC grants with international collaborators", "result": "Case studies used to demonstrate and promote the value of international collaboration", "status": "Achieved", "source_page": 1 } ], "_source_urls": { "annual_report_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "corporate_plan_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22" } }, "ideas": [ { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Risk & Assurance", "scale": "small", "title": "Recommendation tracker for audits, reviews, and inquiries", "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.", "quote": "For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Risk & Assurance", "scale": "large", "title": "Integrated assurance and lessons-learned system", "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.", "quote": "For the purpose of this definition, 'cost' includes any cost\ndirectly attributable to obtaining the Asset in the condition necessary for use in the\nrelevant Research Activity;\n\"Audited Financial Statement\" has the meaning given in clauses 10.15 to 10.17;\n\"Australian Accounting Standards\" refers to the standards of that name, as\namended from time to time, that are maintained by the Australian Accounting\nStandards Board referred to in section 227 of the Australian Securities and\nInvestments Commission Act 2001 (Cth);\n\"Australian Auditing Standards\" refers to the standards of that name, as amended\nfrom time to time, that are made by the Auditing and Assurance Standards Board\ncreated by section 227A of the Australian Securities and Investments Commission Act\n2001 (Cth);\n“Australian Medical Research and Innovation Priorities” means the priorities\ndetermined under section 32E of the Act;", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Case Processing", "scale": "small", "title": "Triage queue for stuck or ageing cases", "idea": "Use existing case data to flag ageing, duplicate, incomplete, or high-risk cases for earlier intervention.", "quote": "Activity of the Committee\nThere were a total of 11 meetings held to review the 20 applications:\n 2 meetings where 3 applications were reviewed\n 5 meetings where 2 applications were reviewed\n 4 meetings where 1 application was reviewed\nThe average time from submission of a complete application to meeting was 22.3 calendar days.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Applicants / case officers", "source": "reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Case Processing", "scale": "large", "title": "End-to-end case processing redesign", "idea": "Redesign the case pathway around risk-based triage, reusable evidence, and automated eligibility checks.", "quote": "Activity of the Committee\nThere were a total of 11 meetings held to review the 20 applications:\n 2 meetings where 3 applications were reviewed\n 5 meetings where 2 applications were reviewed\n 4 meetings where 1 application was reviewed\nThe average time from submission of a complete application to meeting was 22.3 calendar days.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Applicants / case officers", "source": "reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Staff Productivity", "scale": "small", "title": "Reusable briefing and summary assistant for internal documents", "idea": "Create controlled templates for summarising reports, submissions, minutes, and ministerial briefs.", "quote": "The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Staff Productivity", "scale": "large", "title": "Department-wide knowledge and briefing platform", "idea": "Build a secure knowledge platform that lets staff search, summarise, and cite approved departmental material.", "quote": "The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Regulation & Policy", "scale": "small", "title": "Regulatory burden scan for forms, guidance, and reporting", "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.", "quote": "3\nWHO's Strategic Priorities on Antimicrobial Resistance includes 'research and development for better access to quality AMR prevention and care', which aims to promote scientific interest, research and investment in new tools and policy guidance relevant to the AMR response.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Regulation & Policy", "scale": "large", "title": "Adaptive regulation program with live feedback loops", "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.", "quote": "3\nWHO's Strategic Priorities on Antimicrobial Resistance includes 'research and development for better access to quality AMR prevention and care', which aims to promote scientific interest, research and investment in new tools and policy guidance relevant to the AMR response.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "pages/strategies-index__06.html (http://www.nhmrc.gov.au/node/8221)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Data & Performance", "scale": "small", "title": "KPI evidence register with named owners", "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.", "quote": "[Page 39]\nComment\nEligibility criteria\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nSample size Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nStatistical analysis plan Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nData management plan Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nRisk profile (protocol) Comment\n☐ Appropriate\nPage 40 of 41", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Data & Performance", "scale": "large", "title": "Outcome dashboard linking budget, delivery, and public impact", "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.", "quote": "[Page 39]\nComment\nEligibility criteria\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nSample size Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nStatistical analysis plan Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nData management plan Comment\n☐ Appropriate\n☐ Sufficient\n☐ Deficient\nRisk profile (protocol) Comment\n☐ Appropriate\nPage 40 of 41", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "reviews/final-report-national-scientific-committees.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Citizen Participation", "scale": "small", "title": "Consultation feedback summaries with response tracking", "idea": "Summarise consultation submissions by theme and publish what changed in response.", "quote": "The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "category": "Citizen Participation", "scale": "large", "title": "Always-on policy participation platform", "idea": "Create a standing participation platform where citizens and stakeholders can propose, vote, and track ideas.", "quote": "The Strategy identifies 4 key priorities for international engagement:\nPriority 1 – Collaboration in the Indo-Pacific region: NHMRC fosters health research collaboration in the Indo-Pacific region and contributes to regional research capacity building\nPriority 2 – Shared global health priorities: NHMRC grants support research on shared global health priorities to build a healthy Australia and world\nPriority 3 – Researcher capability and research impact: NHMRC facilitates international collaboration and researcher exchange to build Australian research capability and impact\nPriority 4 – International networks and resources: Australian researchers have access to and benefit from international expertise, resources and best practice in the conduct of research\nDeveloped through consultation with other Australian Government agencies, our\nStrategic Opportunities report", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "pages/strategies-index.html (http://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] } ], "legislation_administered": [], "artifacts": [ { "category": "strategies", "year": "2023", "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf", "file": "strategies/International-Engagement-Strategy-2023-2026.pdf", "bytes": 247028, "link_text": "International Engagement Strategy 2023–2026" }, { "category": "strategies", "year": null, "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC_Gender_Equity_Strategy_FA.pdf", "file": "strategies/NHMRC_Gender_Equity_Strategy_FA.pdf", "bytes": 112699, "link_text": "NHMRC Gender Equity Strategy" }, { "category": "reviews", "year": null, "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf", "file": "reviews/final-report-national-scientific-committees.pdf", "bytes": 1962346, "link_text": "Report from the pilot – National Scientific Committee" }, { "category": "other-pdfs", "year": null, "url": "https://www.nhmrc.gov.au/sites/default/files/images/NHMRC-ARC%20AI%20joint%20statement%20policy%20on%20use%20of%20generative%20AI%20in%20grant%20applications%20and%20assessment.pdf", "file": "other-pdfs/NHMRC-ARC-20AI-20joint-20statement-20policy-20on-20use-20of-20generative-20AI-20.pdf", "bytes": 93728, "link_text": "NHMRC-ARC joint statement policy on use of generative AI in grant applications and assessment" }, { "category": "other-pdfs", "year": "2025", "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Research%20Administration/NHMRC-Administering-%20Institution-Status-Application-Form-2.pdf", "file": "other-pdfs/NHMRC-Administering--20Institution-Status-Application-Form-2.pdf", "bytes": 649871, "link_text": "NHMRC Administering Institution status application form (14 November 2025)" }, { "category": "other-pdfs", "year": "2025", "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC-Approved-Administering-Institutions.pdf", "file": "other-pdfs/NHMRC-Approved-Administering-Institutions.pdf", "bytes": 196666, "link_text": "NHMRC Administering Institutions list (as at 20 November 2025)" }, { "category": "other-pdfs", "year": "2025", "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf", "file": "other-pdfs/Nov-21-MRFF-Funding-Agreement-CURRENT-2025.pdf", "bytes": 1493886, "link_text": "MRFF Funding Agreement" }, { "category": "other-pdfs", "year": null, "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/grant%20documents/Example%20MRFF%20Grant%20Schedule%20Template.pdf", "file": "other-pdfs/Example-20MRFF-20Grant-20Schedule-20Template.pdf", "bytes": 220803, "link_text": "Example MRFF Grant Schedule Template" }, { "category": "annual-reports", "year": "2018", "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "file": "annual-reports/2018.pdf", "bytes": 1590102, "link_text": "Annual Report" }, { "category": "corporate-plans", "year": "2018", "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf#search=%22corporate%20plan%20NHMRC%202018-19%22", "file": "corporate-plans/2018.pdf", "bytes": 1590102, "link_text": "Corporate Plan" } ], "_meta": { "snapshot_built_at": "2026-05-13T11:02:56+00:00", "strategy_brief_meta": { "model": "nova-micro", "folder": "National-Health-and-Medical-Research-Council", "annual_report": { "file": null, "url": "", "year": null }, "corporate_plan": { "file": "strategies\\International-Engagement-Strategy-2023-2026.txt", "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf", "year": "International-Engagement-Strategy-2023-2026" }, "usage": { "input_tokens": 1609, "output_tokens": 582, "total_tokens": 2191, "model": "nova-micro" }, "cost_usd": 0.00013779500000000002, "elapsed_seconds": 2.18, "generated_at": "2026-05-13T10:33:35+00:00" }, "ideas_manifest": { "entity_id": "O-000876", "entity_name": "National Health and Medical Research Council", "folder_name": "National-Health-and-Medical-Research-Council", "generated_at": "2026-05-09T23:05:05.031844+00:00", "idea_count": 12, "markdown": "ideas/National-Health-and-Medical-Research-Council_ideas.md", "jsonl": "ideas/ideas.jsonl", "inputs": [ "National-Health-and-Medical-Research-Council_strategy-overview.md", "strategy-evidence.json", "global-intelligence/source-manifest.json" ] }, "global_intel_meta": null } }